Heparin and citrate additive carryover during blood collection

Martin Keppel (Erstautor/-in), Simon Auer (Co-Autor/-in), Giuseppe Lippi, Alexander von Meyer, Michael Cornes, Thomas Felder (Co-Autor/-in), Hannes Oberkofler, Cornelia Mrazek (Co-Autor/-in), Elisabeth Haschke-Becher (Co-Autor/-in), Janne Cadamuro* (Letztautor/-in)

*Korrespondierende/r Autor/-in für diese Arbeit

Publikation: Beitrag in FachzeitschriftOriginalarbeitBegutachtung

6 Quellenangaben (Web of Science)

Abstract

Background Published evidence on the risk of additive carryover during phlebotomy remains elusive. We aimed to assess potential carryover of citrated and heparinized blood and the relative volume needed to bias clinical chemistry and coagulation tests. Methods We simulated standardized phlebotomies to quantify the risk of carryover of citrate and heparin additives in distilled water, using sodium and lithium as surrogates. We also investigated the effects of contamination of heparinized blood samples with increasing volumes of citrated blood and pure citrate on measurements of sodium, potassium, chloride, magnesium, total and ionized calcium and phosphate. Likewise, we studied the effects of contamination of citrated blood samples with increasing volumes of heparinized blood on heparin (anti-Xa) activity, lithium, activated partial thromboplastin time (APTT), prothrombin time (PT) and thrombin time (TT). We interpreted these results based on measurement deviations beyond analytical, biological and clinical significance. Results Standardized phlebotomy simulations revealed no significant differences in concentration of surrogate markers. Clinically significant alterations were observed after contamination of heparinized blood samples with volumes of citrated blood beyond 5-50 μL for ionized calcium and beyond 100-1000 μL for sodium, chloride and total calcium. Investigations of pure citrate carryover revealed similar results at somewhat lower volumes. Heparinized blood carryover showed clinically significant interference of coagulation testing at volumes beyond 5-100 μL. Conclusions Our results suggest that during a standardized phlebotomy, heparin or citrate contamination is highly unlikely. However, smaller volumes are sufficient to severely alter test results when deviating from phlebotomy guidelines.
OriginalspracheEnglisch
Seiten (von - bis)1888-1896
FachzeitschriftCLINICAL CHEMISTRY AND LABORATORY MEDICINE
Jahrgang57
Ausgabenummer12
DOIs
PublikationsstatusVeröffentlicht - 5 Aug. 2019

Fingerprint

Untersuchen Sie die Forschungsthemen von „Heparin and citrate additive carryover during blood collection“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren